Expression of Egfl7 and miRNA-126-5p in Symptomatic Carotid Artery Disease
dc.authorid | bermek, hakan/0000-0003-2911-7678|CATAL, TUNC/0000-0003-2990-8680 | |
dc.authorwosid | bermek, hakan/S-7118-2018 | |
dc.authorwosid | Catal, Tunc/AAO-1200-2020 | |
dc.authorwosid | Zeybek, Sakir Umit/AAD-2960-2020 | |
dc.contributor.author | Sezer Zhmurov, Cigdem | |
dc.contributor.author | Timirci-Kahraman, Ozlem | |
dc.contributor.author | Amadou, Fatimat'ul Zahara | |
dc.contributor.author | Fazliogullari, Osman | |
dc.contributor.author | Basaran, Cem | |
dc.contributor.author | Catal, Tunc | |
dc.contributor.author | Zeybek, Umit | |
dc.date.accessioned | 2024-07-18T20:45:35Z | |
dc.date.available | 2024-07-18T20:45:35Z | |
dc.date.issued | 2016 | |
dc.department | İstanbul Bilgi Üniversitesi | en_US |
dc.description.abstract | Background: Neoangiogenesis inside the atherosclerotic plaques has been linked to progression of the disease. Egfl7, a key player in adult angiogenesis, was found to be upregulated in response to vascular injury in rats. Egfl7 encodes for miR-126-3p and miR-126-5p. Specific information about miRNA-126-5p and its expression in cardiovascular disease is scarce in comparison to that of miR-126-3p. Objectives: A gene expression study was conducted to investigate the levels of Egfl7 and miRNA126-5p in human carotid artery atherosclerotic plaques aiming to gain a better understanding of the role of neoangiogenesis within plaques and the mechanisms causing atherosclerosis progression. Methods:Egfl7 and miR-126-5p levels were studied in 14 plaque samples and 14 control samples using real-time PCR. The fold change between the carotid artery plaque tissue and control tissue was calculated using the 2(-CT) method. Results:Egfl7 was upregulated in the 11 plaque samples compared to controls, while expression levels of miR-126-5p was higher in eight of the plaque samples and lower in six as compared to control samples. Upregulation of miR-126-5p expression was correlated with high low-density lipoprotein (LDL) cholesterol (p=0.023). Conclusions: Our findings suggest that the upregulation of Egfl7 promotes neoangiogenesis within the plaques, contributing to disease progression. | en_US |
dc.description.sponsorship | Istanbul Technical University Scientific Research Projects Unit (ITU/BAP) [36999] | en_US |
dc.description.sponsorship | This work was supported by the Istanbul Technical University Scientific Research Projects Unit (ITU/BAP) (Grant Number 36999). The authors thank Faruk Celik, Servet Tunoglu, and Ece Gizem Isikoren for all their help and support. | en_US |
dc.identifier.doi | 10.1089/gtmb.2015.0252 | |
dc.identifier.endpage | 129 | en_US |
dc.identifier.issn | 1945-0265 | |
dc.identifier.issn | 1945-0257 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 26799121 | en_US |
dc.identifier.scopus | 2-s2.0-84960874047 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 125 | en_US |
dc.identifier.uri | https://doi.org/10.1089/gtmb.2015.0252 | |
dc.identifier.uri | https://hdl.handle.net/11411/7619 | |
dc.identifier.volume | 20 | en_US |
dc.identifier.wos | WOS:000371881900005 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Mary Ann Liebert, Inc | en_US |
dc.relation.ispartof | Genetic Testing and Molecular Biomarkers | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Micrornas | en_US |
dc.subject | Atherosclerosis | en_US |
dc.subject | Mir-126 | en_US |
dc.subject | Angiogenesis | en_US |
dc.title | Expression of Egfl7 and miRNA-126-5p in Symptomatic Carotid Artery Disease | |
dc.type | Article |